A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is
These are peer-reviewed supplementary materials for the article 'Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery dise
